We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Karolinska Institutet

News List

Anticancer drug may improve outcome for severe COVID-19 patients worldpharmanews
February 10, 2021
Treating severe COVID-19 patients with the anticancer drug bevacizumab may reduce mortality and speed up recovery, according to a small clinical study in Italy and China that was led by researchers at Karolinska Institutet in Sweden between February ...
Strong activation of anti-bacterial T cells linked to severe COVID-19 worldpharmanews
September 30, 2020
A type of anti-bacterial T cells, so-called MAIT cells, are strongly activated in people with moderate to severe COVID-19 disease, according to a study by researchers at Karolinska Institutet in Sweden that is published in the journal Science Immunology.
Ferring, Rebiotix and Karolinska Institutet Extend Collaboration to Research Next Generation of Microbiome Treatments pharmafocusasia
January 24, 2019
Ferring Pharmaceuticals and Karolinska Institutet announced today a five-year extension of their collaboration to explore the potential of the human microbiome in reproductive medicine and women’s health and gastroenterology....
Symcel partners with Karolinska Institutet to validate calScreener™ in clinical antimicrobial susceptibility testing biospace
April 13, 2018
Symcel has partnered with the Karolinska Institutet in a Horizon 2020 funded project.